热门资讯> 正文
Voyageur Pharmaceuticals通过认购令筹集170万美元
2025-08-20 04:28
- Voyageur Pharmaceuticals (TSXV:VM:CA) received $1.47M in gross proceeds from the exercise of 14.7M share purchase warrants.
- 1.12M of these warrants were exercised by EVP Ethan Mohan.
- These warrants were originally issued in a December 2024 private placement; 523,332 expired on August 18, 2025.
- An additional $215,625 was raised from the exercise of 1.44M warrants from a March 2024 placement.
- 4.67M warrants from the March 2024 placement remain unexercised, expiring March 1, 2026.
- Voyageur now has 178.33M common shares issued and outstanding.
- Source: Press release
More on Voyageur Pharmaceuticals Ltd.
- Financial information for Voyageur Pharmaceuticals Ltd.
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。